Details of the Drug

General Information of Drug (ID: DMFI057)

Drug Name
N-(5-methylthiazol-2-yl)benzamide
Synonyms
N-(5-methyl-1,3-thiazol-2-yl)benzamide; AC1MBAM0; SCHEMBL1270133; CHEMBL390097; MolPort-006-054-218; ZINC3555837; STL456150; AKOS008918901; MCULE-4605210896; KB-102415; N-(5-Methylthiazol-2-yl)benzenecarboxamide; N~1~-(5-methyl-1,3-thiazol-2-yl)benzamide; Z29325335
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 0 Molecular Weight (mw) 218.28
Logarithm of the Partition Coefficient (xlogp) 2.5
Rotatable Bond Count (rotbonds) 2
Hydrogen Bond Donor Count (hbonddonor) 1
Hydrogen Bond Acceptor Count (hbondacc) 3
Chemical Identifiers
Formula
C11H10N2OS
IUPAC Name
N-(5-methyl-1,3-thiazol-2-yl)benzamide
Canonical SMILES
CC1=CN=C(S1)NC(=O)C2=CC=CC=C2
InChI
InChI=1S/C11H10N2OS/c1-8-7-12-11(15-8)13-10(14)9-5-3-2-4-6-9/h2-7H,1H3,(H,12,13,14)
InChIKey
HEGBNFORMCPFKO-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
2673074
TTD ID
D04QVX

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
LOX-5 messenger RNA (ALOX5 mRNA) TTSJ6Q4 LOX5_HUMAN Inhibitor [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

Molecular Expression Atlas of This Drug

The Studied Disease Discovery agent
ICD Disease Classification N.A.
Molecule Name Molecule Type Gene Name p-value Fold-Change Z-score
LOX-5 messenger RNA (ALOX5 mRNA) DTT ALOX5 9.43E-03 0.14 0.28
Molecular Expression Atlas (MEA) Jump to Detail Molecular Expression Atlas of This Drug

References

1 Identification of natural-product-derived inhibitors of 5-lipoxygenase activity by ligand-based virtual screening. J Med Chem. 2007 May 31;50(11):2640-6.